Mechanically, TCF7L2 activates NEDD9 transcription by directly binding to NEDD9 promoter region, and NEDD9 can activate the AKT/mTOR pathway, thereby promoting the migration and invasion of HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.